In 2023, Matthew L. Trerotola earned $1.29M in total compensation at AptarGroup, including $1.12M salary and $168.00K bonus. Most recently acquired 47,394 shares in Feb 2025. Currently holds stock worth $13.59M. 2+ years at the helm of AptarGroup.
Compensation History
Annual executive compensation data for Matthew L. Trerotola, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.29M
Salary
$1.12M
Bonus
$168.00K
Other
$0.00
Salary
$1.12MBoard Justification
The compensation philosophy is designed to fairly reward executives for growing the business and increasing value for stockholders, with a significant portion of pay being performance-based and delivered in equity.
Bonus
$168.00KBoard Justification
Performance recognition bonuses based on the company's achievements in 2023, awarded in early 2024.
Other Compensation
$0.00Board Justification
No additional compensation reported outside of salary, bonus, and stock options.
Restricted Stock
Board Justification
No stock grants vested in 2023 as the focus is on performance-based compensation and long-term incentives.
Performance Metrics
Performance metrics include STI Adjusted EBITDA growth, core sales growth, and an optimization initiative to manage costs.
Matthew L. Trerotola
CEO of AptarGroup
Education
N/A
Sector of Economy
Healthcare
Born
January 1, 1966 - 59 years ago
CEO of AptarGroup for
2 years 7 months (May 2023 - Present)
Previous Experience
President and CEO of Enovis Corporation, former roles in various leadership positions in the medical technology sector.
Other AptarGroup CEOs
Holdings
Track Matthew L. Trerotola's stock holdings and portfolio value over time.
Total Stock Sold
$1.93M
$1.93M
33,385 ENOV shares
What if they kept their stock?
If Matthew L. Trerotola didn't sell their stock, today they would have:
Extra ENOV33,385 shares worth $902.06K.
This is -53.2% and $1.03M less than what they got when they sold the stock.
Insider Trading
Matthew L. Trerotola's recent stock transactions, purchases, and sales filed with the SEC.
47,394 shares
ENOV
Feb 17, 2025
Received
64,484 shares
ENOV
Mar 4, 2024
Received
45,635 shares
ENOV
Feb 22, 2024
Received
$389.00K
ENOV at $57.69/share
Mar 6, 2023
Sale
60,504 shares
ENOV
Feb 27, 2023
Received
$1.06M
ENOV at $56.21/share
Feb 27, 2023
Sale
$450.87K
ENOV at $58.36/share
Feb 21, 2023
Sale
$24.00K
DD at $69.12/share
Jun 12, 2015
Received
$22.89K
DD at $80.50/share
Mar 13, 2015
Received
5,764 shares
DD
Feb 4, 2015
Received
Rivals
Compare Matthew L. Trerotola with competitor CEOs and industry peers.